Inventiva SA (IVA) Earnings Date & Reports

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IVA is expected to report earnings to fall 69.35% to -55 cents per share on September 25

Q2'25

Est.

$-0.56

Q4'24

Missed

by $1.39

Q3'24

Missed

by $0.20

Q2'24

Missed

by $0.17

Q1'24

Beat

by $0.04

The last earnings report on March 26 showed earnings per share of -182 cents, missing the estimate of -43 cents. With 15.37K shares outstanding, the current market capitalization sits at 304.62M.

View a ticker or compare two or three

Compare

IVA